Suchbegriffe: ENDOMETRIAL STROMAL SARCOMA, . Treffer: 31
Denschlag, D; Ackermann, S; Battista, MJ; Cremer, W; Egerer, G; Fehr, M; Follmann, M; Haase, H; Harter, P; Hettmer, S; Horn, LC; Juhasz-Boess, I; Kast, K; Köhler, G; Kröncke, T; Lindel, K; Mallmann, P; Meyer-Steinacker, R; Mustea, A; Petru, E; Reichardt, P; Schmidt, D; Strauss, HG; Thiel, F; Ulrich, UA; Vogl, T; Vordermark, D; Wallwiener, M; Gass, P; Beckmann, MW
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021).
Geburtshilfe Frauenheilkd. 2022; 82(12):1337-1367
Doi: 10.1055/a-1897-5124
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Ling, F; Ruan, S; Chen, H; Xiong, X; Zhao, D; Haybaeck, J; Zhang, C
Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With BCOR Gene Alterations: A Case Report.
In Vivo. 2022; 36(4): 1971-1976.
Doi: 10.21873/invivo.12920
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Denschlag, D; Ackermann, S; Battista, MJ; Cremer, W; Egerer, G; Follmann, M; Haas, H; Harter, P; Hettmer, S; Horn, LC; Juhasz-Boess, I; Kast, K; Köhler, G; Kröncke, T; Lindel, K; Mallmann, P; Meyer-Steinacker, R; Mustea, A; Petru, E; Reichardt, P; Schmidt, D; Strauss, HG; Tempfer, C; Thiel, F; Ulrich, U; Vogl, T; Vordermark, D; Gass, P; Beckmann, MW
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019).
Geburtshilfe Frauenheilkd. 2019; 79(10):1043-1060
Doi: 10.1055/a-0882-4116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Cuppens, T; Annibali, D; Coosemans, A; Trovik, J; Ter Haar, N; Colas, E; Garcia-Jimenez, A; Van de Vijver, K; Kruitwagen, RP; Brinkhuis, M; Zikan, M; Dundr, P; Huvila, J; Carpén, O; Haybaeck, J; Moinfar, F; Salvesen, HB; Stukan, M; Mestdagh, C; Zweemer, RP; Massuger, LF; Mallmann, MR; Wardelmann, E; Mints, M; Verbist, G; Thomas, D; Gommé, E; Hermans, E; Moerman, P; Bosse, T; Amant, F
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Clin Cancer Res. 2017; 23(5):1274-1285
Doi: 10.1158/1078-0432.CCR-16-2149
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hrzenjak, A
JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas.
Orphanet J Rare Dis. 2016; 11(6):15-15
Doi: 10.1186/s13023-016-0400-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lax, SF
[New features in the 2014 WHO classification of uterine neoplasms].
Pathologe. 2016; 37(6):500-511
Doi: 10.1007/s00292-016-0230-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Flicker, K; Smolle, E; Haybaeck, J; Moinfar, F
Genomic characterization of endometrial stromal sarcomas with array comparative genomic hybridization.
Exp Mol Pathol. 2015; 98(3):367-374
Doi: 10.1016/j.yexmp.2015.03.009
Web of Science
PubMed
FullText
FullText_MUG
Hrzenjak, A; Dieber-Rotheneder, M; Moinfar, F; Petru, E; Zatloukal, K
Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies.
Cancer Lett. 2014; 354(1):21-27
Doi: 10.1016/j.canlet.2014.08.013
Web of Science
PubMed
FullText
FullText_MUG
Quan, P; Moinfar, F; Kufferath, I; Absenger, M; Kueznik, T; Denk, H; Zatloukal, K; Haybaeck, J
Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.
Anticancer Res. 2014; 34(6):2883-2897
Web of Science
PubMed
Reich, O; Regauer, S; Tempfer, C; Schneeberger, C; Huber, J
Polymorphism 1558 C > T in the aromatase gene (CYP19A1) in low-grade endometrial stromal sarcoma
EUR J GYNAECOL ONCOL. 2011; 32(6): 626-627.
Doi: 10.1055/s-0030-1254973
Web of Science
FullText
FullText_MUG
Reich, O; Regauer, S; Scharf, S
High levels of xenoestrogens in patients with low-grade endometrial stromal sarcoma - report of two cases
EUR J GYNAECOL ONCOL. 2010; 31(1): 105-106.
Web of Science
Hrzenjak, A; Kremser, ML; Strohmeier, B; Moinfar, F; Zatloukal, K; Denk, H
SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.
J Pathol. 2008; 216(4):495-504
Doi: 10.1002/path.2434
Web of Science
PubMed
FullText
FullText_MUG
Liegl, B; Gülly, C; Reich, O; Nogales, FF; Beham, A; Regauer, S
Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.
Histopathology. 2007; 50(4):448-452
Doi: 10.1111/j.1365-2559.2007.02634.x
Web of Science
PubMed
FullText
FullText_MUG
Moinfar, F; Azodi, M; Tavassoli, FA
Uterine sarcomas.
PATHOLOGY. 2007; 39(1): 55-71.
Doi: 10.1080/00313020601136146
Web of Science
PubMed
FullText
FullText_MUG
Reich, O; Regauer, S
Hormonal therapy of endometrial stromal sarcoma.
Curr Opin Oncol. 2007; 19(4):347-352
Doi: 10.1097/CCO.0b013e3281a7ef3a
Web of Science
PubMed
FullText
FullText_MUG
Reich, O; Singer, C; Hudelist, G; Regauer, S
Estrogen sulfotransferase expression in endometrial stromal sarcomas: an immunohistochemical study.
PATHOL RES PRACT. 2007; 203(2): 85-87.
Doi: 10.1016/j.prp.2006.10.003
Web of Science
PubMed
FullText
FullText_MUG
Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Staber, PB; Zatloukal, K; Denk, H
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
Mol Cancer Ther. 2006; 5(9):2203-2210
Doi: 10.1158/1535-7163.MCT-05-0480
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Klaritsch, P; Reich, O; Regauer, S; Bauernhofer, T
Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report.
Eur J Gynaecol Oncol. 2006; 27(3):297-298
(- Case Report)
Web of Science
PubMed
Reich, O; Regauer, S
Survey of adjuvant hormone therapy in patients after endometrial stromal sarcoma.
Eur J Gynaecol Oncol. 2006; 27(2):150-152
Web of Science
PubMed
Halbwedl, I; Ullmann, R; Kremser, ML; Man, YG; Isadi-Moud, N; Lax, S; Denk, H; Popper, HH; Tavassoli, FA; Moinfar, F
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization.
GYNECOL ONCOL. 2005; 97: 582-587.
Doi: 10.1016/j.ygyno.2005.01.002
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Hrzenjak, A; Moinfar, F; Tavassoli, FA; Strohmeier, B; Kremser, ML; Zatloukal, K; Denk, H
JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.
J MOL DIAGN. 2005; 7(3): 388-395.
Doi: 10.1016/S1525-1578(10)60568-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Moinfar, F; Gogg-Kamerer, M; Sommersacher, A; Regitnig, P; Man, YG; Zatloukal, K; Denk, H; Tavassoli, FA
Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach.
AMER J SURG PATHOL. 2005; 29(4): 485-489.
Doi: 10.1097%2F01.pas.0000155149.83541.24
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Reich, O; Nogales, FF; Regauer, S
Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study.
Mod Pathol. 2005; 18(4):573-576
Doi: 10.1038/modpathol.3800325
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Reich, O; Regauer, S
Endometrial stromal sarcoma--observational evidence of a genetic background?
Eur J Gynaecol Oncol. 2005; 26(3):288-290
Web of Science
PubMed
Hrzenjak, A; Tippl, M; Kremser, ML; Strohmeier, B; Guelly, C; Neumeister, D; Lax, S; Moinfar, F; Tabrizi, AD; Isadi-Moud, N; Zatloukal, K; Denk, H
Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas.
J PATHOL. 2004; 204(1): 19-27.
Doi: 10.1002/path.1616
Web of Science
PubMed
FullText
FullText_MUG
Moinfar, F; Kremser, ML; Man, YG; Zatloukal, K; Tavassoli, FA; Denk, H
Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues.
GYNECOL ONCOL. 2004; 95(3): 662-671.
Doi: 10.1016/j.ygyno.2004.08.016
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Moinfar, F; Regitnig, P; Tabrizi, AD; Denk, H; Tavassoli, FA
Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.
VIRCHOWS ARCHIV. 2004; 444(5): 410-414.
Doi: 10.1007/s00428-004-0981-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Reich, O; Regauer, S
Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study.
Mod Pathol. 2004; 17(1):104-108
Doi: 10.1038/sj.modpathol.3800031
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Reich, O; Pickel, H; Regauer, S
Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.
Acta Cytol. 2002; 46(4):790-792
(- Case Report)
Web of Science
PubMed
Bodner, K; Bodner-Adler, B; Obermair, A; Windbichler, G; Petru, E; Mayerhofer, S; Czerwenka, K; Leodolter, S; Kainz, C; Mayerhofer, K
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Gynecol Oncol. 2001; 81(2):160-165
Doi: 10.1006/gyno.2001.6152
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Reich, O; Regauer, S; Urdl, W; Lahousen, M; Winter, R
Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
Br J Cancer. 2000; 82(5):1030-1034
Doi: 10.1054/bjoc.1999.1038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar